Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Bio-Medical Pharmaceutical Manufacturing Corporation
FDA Inspection
•Bio-Medical Pharmaceutical Manufacturing Corporation•August 29, 2025

Bio-Medical Pharmaceutical Manufacturing Corporation – FDA Inspection, Aug 29, 2025

Record Details

This FDA Inspection record concerns Bio-Medical Pharmaceutical Manufacturing Corporation, with an inspection on August 29, 2025, issued by the Dallas District Office, covering human drugs.

Company
Bio-Medical Pharmaceutical Manufacturing Corporation
Inspection Date
August 29, 2025
Product Type
Human Drugs
Office
Dallas District Office
People
  • Milton J. De Jesus Tavarez (Issuing Officer)
  • Ronda R. Lloyd-Jones (FDA Associated Person)
View Company Profile

ID · 2e75434d-d166-4fba-abb3-793f551fde33

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1279930
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

9
  1. 21 CFR 211.142(b)Storage under appropriate conditions
  2. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  3. 21 CFR 211.63Equipment Design, Size and Location
  4. 21 CFR 211.113(b)Procedures for sterile drug products
  5. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  6. 21 CFR 211.84(c)(4)Top/Middle/Bottom container sampling
  7. 21 CFR 211.165(a)Testing and release for distribution
  8. 21 CFR 211.188(b)(1)Significant Step Accomplishment Dates
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Bio-Medical Pharmaceutical Manufacturing Corporation

3
DateClassificationOfficeProject area
January 23, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 14, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 9, 2010VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Bio-Medical Pharmaceutical Manufacturing Corporation
  • FDA Inspection 1115699 - 2020-01-23
  • FDA Inspection 960788 - 2016-01-14
  • FDA Inspection 671855 - 2010-07-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bio-Medical Pharmaceutical Manufacturing Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.